click below
click below
Normal Size Small Size show me how
Week 5
| Generic | Brand | Class | Indication | BBW | Side Effects | Counseling |
|---|---|---|---|---|---|---|
| Sofosbuvir | Sovaldi | Nucleotide analog NS5B polymerase inhibitor. | Treatment of adult and pediatric patients with chronic HCV infection | Risk of HBV reactivation in patients connected with HCV AND HBV. Test all patients for evidence of current or prior HBV infections before treatment. | Fatigue, headache, nausea, insomnia. Bradycardia can occur when used with amiodarone. | Must be used in combo with other antiviral medications. Not effective as monotherapy. |
| Atazanavir | Reyataz | HIV protease inhibitors | HIV-1 infection in adults and pediatric in combo with other agents | Hyperbilrubinemia (jaundice or yellowing) PR interval prolongation | requires an acidic stomach environment, avoid or space doses significantly from PPI, antacids. Many DDI | |
| Efavirenz | Sustiva | Non-nucleoside reverse transcriptase inhibitors (NNRTI) | HIV-1 infection on combo with other antiretroviral agents | dizziness, insomnia, impaired concentration, vivid dreams. serious depression, suicidal ideation/attempts | Take on a empty stomach | |
| Maraviroc | Selzentry | Antiretroviral, CCR5 Antagonist (Anti-HIV) | CCR5-tropic HIV-1 infection in combo with other antiretroviral agents | Hepatotoxicity | Tropism requirement: before starting, screening test, must confirm the patient has CCR-5. Cough, fever, dizziness | Dose must be adjusted based on concomitant medications |
| Elbasvir/grazoprevir | Zepatier | HCV Direct acting Antiviral (NS5A/NS3/4A) | Treatment of chronic hep C virus genotypes 1 or 4 infection in adults and pediatric patients | HBV reactivation in pt connected with HCV or HBV | Hepatic ALT elevations: monitor ALT prior to drug treatment. Fatigue, headache and nausea. | Report symptoms of liver injury, scubas fatigue, loss of appetite |
| Glecaprevir/Pibrentasvir | Mavyert | HCV Direct acting Antiviral (NS5A/NS3/4A) | Treatment of chronic hep C virus genotypes 1,2,3,4,5 or 6 infection | HBV reactivation in pt connected with HCV or HBV | Headache fatigue, and nausea. CI: Pts with severe hepatic impairment (child Pugh C) | Report signs of liver injury such as yellowing of the skin or eyes . |
| Nystatin systemic | Bio-Statin | Anti-fungal agent | non-esphageal gastrointestinal candidiasis and oropharyngeal candidiasis | Diarrhea, nausea, vomiting. Oral irritation and sensitization. | Shake well before use. swish and swallow, retain the liquid in the mouth as long as possible before swallowing | |
| Nystatin Topical | Mycostatin | Anti-fungal agent | non-esphageal gastrointestinal candidiasis and oropharyngeal candidiasis | irritation, dryness | ||
| Darbepoetin | Aranesp | Hematopoietic agent / ESA | Anemia associated with CKD . Anemia for myelosuppressive chemotherapy. | Increase risk of death, MI, Stroke, VTE. CKD: increase risk of serious cardiovascular events Cancer: risk of tumor progression | HTN, cough, abdominal pain. Seizures and serious allergic reaction. SJS | Do not sake the vial or syringe . monitor hemoglobin levels |
| Epoetin Alfa | Epogen/ Procrit | Hematopoietic agent / ESA | Anemia associated with CKD . Anemia for myelosuppressive chemotherapy. | Increase risk of death, MI, Stroke, VTE. CKD: increase risk of serious cardiovascular events Cancer: risk of tumor progression | HTN, cough, abdominal pain. Seizures and serious allergic reaction. SJS | Do not sake the vial or syringe . monitor hemoglobin levels |
| Entecavir | Baraclude | nucleoside reverse transcriptase inhibitor (NRTI) | Hepatitis B | Severe acute exacerbation pf hep B upon d/c. Risk of lactic acidosis and severe hepatomegaly. | Headache, fatigue, dizziness, nausea. Montoir LFT | Take on an empty stomach |